Halozyme Therapeutics, Inc. (NASDAQ:HALO)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Caps

How do you think HALO will perform against the market?

Add Stock to CAPS Watchlist

All Players

297 Outperform
41 Underperform
 

All-Star Players

46 Outperform
8 Underperform
 

Wall Street

14 Outperform
2 Underperform
 

Top HALO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

manirg (< 20)
Submitted October 16, 2014

undervalued

davidmelnikov (< 20)
Submitted December 19, 2006

1. roche deal not that great.2. stock overvalued3. company exists of 19 employees4. no disaster recovery in place, company can be wiped out.5. to many pumpers/blogs bringing the stock price up for no reason.

HALO VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about HALO.

Recs

0
Member Avatar adamicius (< 20) Submitted: 3/8/2017 12:29:58 PM : Outperform Start Price: $13.15 HALO Score: +23.11

A biotech which is yet to make a profit, but has a rather impressive range of projects and partners (Roche, JNJ, AbbVie, Merck). Among other things, it develops advanced techniques for subcutaneous injections of various drugs. The investment is highly speculative.

Recs

0
Member Avatar wisnasty60 (< 20) Submitted: 7/8/2016 12:40:08 PM : Outperform Start Price: $9.19 HALO Score: +66.01

An established biotech company with a successful approved delivery platform with partnerships with other major pharmaceutical drug companies. The company also has a pancreatic drug treatment in phase III trials that has the potential to treat a disease without many viable treatment options.

Recs

0
Member Avatar TMFTypeoh (85.06) Submitted: 8/26/2015 4:31:57 PM : Outperform Start Price: $17.68 HALO Score: -31.10

interesting company with an interesting edge.

Leaderboard

Find the members with the highest scoring picks in HALO.

Score Leader

unguja64

unguja64 (46.74) Score: +474.86

The Score Leader is the player with the highest score across all their picks in HALO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
unguja64 46.74 8/25/2006 Outperform 3Y $2.48 +578.54% +103.68% +474.86 1 Comment
coach1983 < 20 9/18/2006 Outperform 3Y $2.54 +562.99% +100.51% +462.48 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. foolduke 79.22 11/20/2006 Outperform NS $2.65 +535.47% +88.40% +447.07 0 Comment
acsimon < 20 10/16/2006 Outperform NS $2.67 +530.71% +93.55% +437.16 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. pokerden < 20 10/11/2006 Outperform 3Y $2.68 +528.36% +95.96% +432.40 1 Comment
Quality101 < 20 9/21/2006 Outperform 3Y $2.68 +528.36% +98.84% +429.52 1 Comment
czg3000 46.51 11/24/2006 Outperform 1Y $2.80 +501.43% +88.40% +413.03 0 Comment
Joe1988 60.76 11/24/2006 Outperform 1Y $2.82 +497.16% +89.07% +408.09 2 Comments
kh00 71.17 11/30/2006 Outperform 3Y $2.85 +490.88% +87.24% +403.64 0 Comment
dawg99pound < 20 11/27/2006 Outperform NS $2.88 +484.72% +88.46% +396.27 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJPMorgan 89.00 7/11/2014 Outperform NS $9.68 +73.97% +26.86% +47.10 0 Comment
TrackUBS 93.35 6/12/2014 Outperform NS $9.67 +74.15% +27.89% +46.26 0 Comment
TrackCitigroup 94.28 4/15/2014 Outperform NS $7.75 +117.29% +35.79% +81.50 0 Comment
TrackPiperJaff 86.71 5/15/2013 Outperform NS $6.97 +141.61% +50.90% +90.70 0 Comment
TrackBMOCapital < 20 1/14/2013 Outperform NS $7.87 +113.98% +69.47% +44.51 0 Comment
TrackJimCramer 84.63 1/18/2012 Outperform 3W $10.45 +61.15% +90.36% -29.21 0 Comment
TrackUltraLong < 20 12/23/2011 Underperform NS $9.74 +72.90% +98.08% +25.19 1 Comment
TrackJMP 84.37 10/19/2011 Outperform NS $7.32 +130.05% +103.41% +26.65 0 Comment
TrackStifel 94.51 4/1/2011 Outperform NS $6.99 +140.92% +86.59% +54.33 0 Comment
TrackBarclaysCap 93.35 10/6/2010 Outperform NS $7.99 -10.39% +47.00% -57.39 8/5/2013 @ $7.16 0 Comment
TrackWMBlair 78.16 4/8/2010 Outperform NS $8.30 +102.89% +111.05% -8.16 0 Comment
TrackBreanMurray 77.79 3/22/2010 Outperform NS $8.50 +98.12% +115.88% -17.76 0 Comment
TrackRothCapital 71.26 4/29/2009 Outperform NS $6.30 +0.79% +56.68% -55.89 5/3/2011 @ $6.35 0 Comment
TrackWedbush 86.63 4/21/2009 Outperform NS $5.40 +211.85% +197.50% +14.36 0 Comment
trackmerriman 74.17 2/26/2009 Outperform NS $5.06 +232.81% +225.60% +7.20 0 Comment
TrackMorganJos 77.70 9/11/2007 Underperform NS $9.17 +83.64% +79.19% -4.46 0 Comment
TrackOppenheimer 70.45 7/24/2007 Outperform NS $9.28 +81.47% +71.13% +10.33 0 Comment
TrackJimCramer 84.63 12/13/2006 Underperform 3W $7.07 +47.81% -8.18% -55.99 1/19/2012 @ $10.45 0 Comment
TrackBreanMurray 77.79 12/7/2006 Outperform NS $4.58 +48.47% -8.62% +57.09 8/11/2008 @ $6.80 0 Comment
TrackJefferies 85.72 12/1/2006 Outperform NS $2.89 +482.70% +88.01% +394.69 0 Comment
TrackRothCapital 71.26 8/11/2006 Outperform NS $2.28 +338.60% +18.83% +319.77 5/14/2007 @ $10.00 0 Comment

Featured Broker Partners